Technologies

Choose category you want to search

Know the name of the technology or research?

9 Results were found on "Pharma" technology category.

Prevent Future Allergies from Infancy

Preventing common future food allergies from day zero with a special formulation for infants

Inventors:

Dr. Idit Lachover, Meir Medical Center
Prof. Raanan Shamir, Shneider Children's Medical Center
More Info Arrow down

An IV-Delivered Treatment for AMD and Neurodegenerative Ocular Diseases

Activated Protein C (APC) for the treatment of Age Related Macular Degeneration (AMD) delivered via IV, avoiding costly and painful ocular injections.

Inventors:

Prof. Dov Weinberger, Rabin Medical Center
Prof. Tami Livnat, Rabin Medical Center
Yael Nisgav, Rabin Medical Center
More Info Arrow down

Preventing Brain Damage after Bypass Surgery

Preoperative administration of Alpha 1 anti-trypsin can prevent post cardiac surgery brain injury as well as short and long term cognitive loss.

Inventors:

Dr Dan Abramov, Soroka Medical Center
More Info Arrow down

Treating Ocular Diseases at the Cell Level

A therapeutic modality for treating ocular disease by using preserved (frozen) mitochondrial transplantation.

Inventors:

Dr. Ziv Rotfogel, Kaplan Medical Center
Dr. Avital Eisenberg, Kaplan Medical Center
More Info Arrow down

Mitigating Myocardial Injury

Novel TLR4 inhibitors as potential cardioprotective therapeutic agents following myocardial infarction (MI)

Inventors:

Prof. Edith Hochhauser, Felsentein and Rabin Medical Center
More Info Arrow down

Two Game-changers Join Forces Against Solid Cancer

A Novel Combination of CDK4/6 and MTK (Multityrosine Kinase) Inhibitors for Treating Refractory Cancer

Inventors:

Prof. Salomon Stemmer, Rabin Medical Center
More Info Arrow down

Treating Cholangiopathy

Nanoparticles of N-Acetyl-Cysteine for treatment of biliary duct diseases, which may lead to serious liver damage

Inventors:

Dr. Orit Waisbourd-Zinman, Schneider Children's Medical Center
More Info Arrow down

Reducing Risk of PVR

A novel therapeutic modality to reduce the risk of Proliferative Retinopathy (PVR) utilizing a new small molecule as TAK1 inhibitor.

Inventors:

Prof. Ayala Pollack, Kaplan Medical Center
More Info Arrow down

Reducing Statin-induced Myopathy

A novel approach to treating HMGCR hereditary and statin-induced myopathy with D-mevalonolactone

Inventors:

Prof. Ohad Birk, Soroka Medical Center
Dr. Yuval Yogev, Soroka Medical Center
More Info Arrow down